DESCRIPTION:

I will review all relevant updates from our program accomplishments from the last 3 years since my last talk, in the background of general progress in the myeloma field.

 

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Identify changing practice of treatment of newly diagnosed myeloma
  • Describe evolving methods of measuring MRD and incorporating MRD results into practice
  • Describe evolving role of immunotherapies in earlier lines of treatment of multiple myeloma
Session date: 
05/05/2025 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Andrzej Jakubowiak, MD, PhD